Odn 2006 Invivogen

CNX-2006

B3227-25 25 mg
EUR 517.2
Description: CNX-2006, a structural analog of CO-1686, is a selective and irreversible inhibitor of mutant-EGFR with IC50 value of < 20 nM.

Human IgG antibody Laboratories manufactures the odn 2006 invivogen reagents distributed by Genprice. The Odn 2006 Invivogen reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact InVivoGen. Other Odn products are available in stock. Specificity: Odn Category: 2006 Group: Invivogen

ODN 2006-Type B (human)

5 mg
EUR 5322
Description: ODN 2006-Type B, human TLR9 agonist, oligodeoxy nucleotide vaccine adjuvant.

True north Cryobox 0.2mLNatural

PK10
EUR 172.8

True north Cryobox 0.5mLNatural

PK10
EUR 153.6

True north Cryobox1.5/2mLNatural

PK10
EUR 100.8

True north Cryobox 5mLNatural

PK10
EUR 153.6

True north Cryobox 5mLBlue

PK10
EUR 153.6

True north Cryobox 15mLNatural

PK10
EUR 212.4

Invivogen information

ODN 2336-Type A (human)

VAdv-Ly0065-5mg 5 mg
EUR 5322
Description: ODN 2336-Type A, human TLR9 agonist, oligodeoxy nucleotide vaccine adjuvant.

ODN 2216-Type A (human)

VAdv-Ly0066-1mg 1 mg
EUR 1693.2
Description: ODN 2216-Type A, human TLR9 agonist, oligodeoxy nucleotide vaccine adjuvant.

ODN 2216-Type A (human)

VAdv-Ly0066-5mg 5 mg
EUR 5322
Description: ODN 2216-Type A, human TLR9 agonist, oligodeoxy nucleotide vaccine adjuvant.

ODN 1668-Type B (murine)

VAdv-Ly0067-1mg 1 mg
EUR 1693.2
Description: ODN 1668-Type B, murine TLR9 agonist, oligodeoxy nucleotide vaccine adjuvant.

ODN 1668-Type B (murine)

VAdv-Ly0067-5mg 5 mg
EUR 5322
Description: ODN 1668-Type B, murine TLR9 agonist, oligodeoxy nucleotide vaccine adjuvant.

ODN INH-47-Class R (restricted) inhibitory ODN TLR9 Antagonist-Palindromic variant of ODN INH-1-antigen grade

ODNINH47-1 200 ug
EUR 270

Neutral ODN control ODN without agonistic nor antagonistic activity antigen grade

ODN-NT-1 100 ug
EUR 781.2

ODN INH-18 class R (?restricted?) inhibitory ODN-TLR9 antagonist antigen grade

ODNINH18-1 200 µg
EUR 270

CpG ODN, Class A (Murine)

VAdv-Ly0013 1 mg
EUR 5190
Description: CpG ODN, murine TLR9 agonist, Oligodeoxy Nucleotide vaccine adjuvant.

ODN 2395-Type C (human/murine)

VAdv-Ly0064-1mg 1 mg
EUR 1693.2
Description: ODN 2395-Type C, human/murine TLR9 agonist, oligodeoxy nucleotide vaccine adjuvant.

ODN 2395-Type C (human/murine)

VAdv-Ly0064-5mg 5 mg
EUR 5322
Description: ODN 2395-Type C, human/murine TLR9 agonist, oligodeoxy nucleotide vaccine adjuvant.

ODN 2007-Type B (Bovine/Porcine)

VAdv-Ly0052-1mg 1 mg
EUR 1693.2
Description: ODN 2007-Type B, bovine/porcine TLR9 agonist, FITC conjugate, oligodeoxy nucleotide vaccine adjuvant.

ODN 2007-Type B (Bovine/Porcine)

VAdv-Ly0052-5mg 5 mg
EUR 5322
Description: ODN 2007-Type B, bovine/porcine TLR9 agonist, FITC conjugate, oligodeoxy nucleotide vaccine adjuvant.

ODN INH-1-Class R (restricted) inhibitory ODN-TLR 9 Antagonist-antigen grade

ODNINH1-1 200 ug
EUR 270

ODN M362-Type C (human/murine)

VAdv-Ly0063-1mg 1 mg
EUR 1693.2
Description: ODN M362-Type C, human/murine TLR9 agonist, oligodeoxy nucleotide vaccine adjuvant.

ODN M362-Type C (human/murine)

VAdv-Ly0063-5mg 5 mg
EUR 5322
Description: ODN M362-Type C, human/murine TLR9 agonist, oligodeoxy nucleotide vaccine adjuvant.

ODN 2216-Type A (human, FITC Conjugate)

VAdv-Ly0048 50 µg
EUR 446.4
Description: ODN 2216-Type A, human TLR9 agonist, FITC conjugate, oligodeoxy nucleotide vaccine adjuvant.